Mortara Instrument to exhibit at FDA/DIA Cardiovascular Safety in Drug Development: State-of-the-art Assessments

March 01, 2011

MILWAUKEE, WI—March 1, 2011—Mortara Instrument will exhibit its complete product portfolio of diagnostic ECG and cardiology monitoring products at FDA/DIA Cardiovascular Safety in Drug Development:  State-of-the-art Assessments hosted at L'Enfant Plaza Hotel in Washington, DC.  Visit http://www.diahome.org/DIAHome/Education/FindEducationalOffering.aspx?productID=24928&eventType=Meeting&rpex=N&evtyp=AMTG,MTG&sdt=03-01-2011 for more information.

Visit us to learn more about Mortara’s go wireless™ technology.

About Mortara Instrument, Inc.

Mortara Instrument's headquarters are located in Milwaukee, Wisconsin with operations in Italy, Germany, Australia, and the Netherlands.  Mortara Instrument is distinguished in the field of non-invasive cardiology innovations that are the core of the company's complete line of ECG products including electrocardiographs, stress exercise systems, Holter systems, data warehousing solutions, and cardiology monitoring systems.  Mortara Instrument manufactures and distributes its ECG devices and related technology worldwide.  The company's website is www.mortara.com.